RE: today's res23 Jul 2021 10:57
Thanks Bothwell, sounds like a promising extract from a company e.mail. I like the bit part about "licensing partners have access to data room". As Bignose noted "Now that the marketing report is finished, there is now something with a lot more substance and of value to bring to the table and since this data will only have a finite timeline, a license agreement could well be in place long before the phase III finishes, although I am beginning to feel it may not now be as lucrative to us shareholders as we have been led to believe." I agree with Bignose and other posters that Fortacin will most likely not be a blockbuster, nonetheless, in light of the current ultra low MCap we should do fairly well once we secure a US license agreement. The combined income from China, EU, Taiwan, HK, Macao, USA and ROW will all add up and with a conservative P/E of 10-15 we must be looking at a multi-bagger from these shocking low levels. Heimdal